www.fdanews.com/articles/120855-fda-approves-pralatrexate-for-treatment-of-peripheral-t-cell-lymphoma
FDA Approves Pralatrexate for Treatment of Peripheral T-Cell Lymphoma
September 29, 2009
The U.S. Food & Drug Administration has announced the approval of pralatrexate for the treatment of relapsed or refractory peripheral T-cell lymphoma.
Earth Times
Earth Times